Dual Tasking in Children With Cerebral Palsy and Healthy Children: an EEG Study (PRALOC)

Processus Attentionnels impliqués Dans la Locomotion Chez l'Enfant à développement Typique et l'Enfant Atteint de Paralysie cérébrale : Une étude EEG.

Simultaneous execution of motor and cognitive tasks is embedded in the daily life of children. An EEG study will be conducted on healthy children and children with cerebral palsy to study the neural correlates during dual tasking while walking

Study Overview

• Status: Unknown
• Conditions: Child Development
• Intervention / Treatment: Behavioral: EEG

Detailed Description

Children will walk at their preferred speed on a treadmill. During dual tasking, they will listen to animals cries and will have to count the number of specified animals cries.

• Study Type: Observational
• Enrollment (Anticipated): 84

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 7 years to 12 years (CHILD)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Healthy children and children with cerebral palsy

Description

Inclusion Criteria:

• normal walking

For children with cerebral palsy: diplegia or hemiplegia, GMFCS 1 or 2, no botulinium injection since 4 months

Exclusion Criteria:

• medical problem

Study Plan

How is the study designed?

Number of groups / cohorts

4

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Children with cerebral palsy 7-9 years; 21 children	Behavioral: EEG; EEG + walking task + auditory task
Children with cerebral palsy 10-12 years; 21 children	Behavioral: EEG; EEG + walking task + auditory task
Healthy children 7-9 years; 21 children	Behavioral: EEG; EEG + walking task + auditory task
Healthy children 10-12 years; 21 children	Behavioral: EEG; EEG + walking task + auditory task

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neural correlates during dual tasking in children	EEG, locomotion parameters, cognitive performances	2 years

Collaborators and Investigators

• Sponsor: University Hospital, Grenoble

Study record dates

Study Major Dates

• Study Start (ANTICIPATED): November 1, 2020
• Primary Completion (ANTICIPATED): September 30, 2022
• Study Completion (ANTICIPATED): September 30, 2022

Study Registration Dates

• First Submitted: September 3, 2020
• First Submitted That Met QC Criteria: November 12, 2020
• First Posted (ACTUAL): November 18, 2020

Study Record Updates

• Last Update Posted (ACTUAL): November 18, 2020
• Last Update Submitted That Met QC Criteria: November 12, 2020
• Last Verified: November 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: 38RC20.067; 2020-A00470-39 (OTHER: ID RCB)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No